Submit Search
Upload
Presynmptoms SARS-Cov-2 Infection and Transmission in Skilled Nursing Facility
•
0 likes
•
223 views
Valentina Corona
Follow
Presynmptoms SARS-Cov-2 Infection and Transmission in Skilled Nursing Facility
Read less
Read more
Health & Medicine
Report
Share
Report
Share
1 of 10
Download now
Download to read offline
Recommended
Asymptomatic Trasmission, the Achilles'Heel of Current Strategies to Control ...
Asymptomatic Trasmission, the Achilles'Heel of Current Strategies to Control ...
Valentina Corona
Mild or Moderete Covid-19
Mild or Moderete Covid-19
Valentina Corona
Hospital care in Department define as Covid-free: A proposal for a safe hospi...
Hospital care in Department define as Covid-free: A proposal for a safe hospi...
Valentina Corona
Journal clinical characteristics covid 19
Journal clinical characteristics covid 19
Shivaom Chaurasia
Baseline characteristics and outcomes of 1591 patients infected with sars co ...
Baseline characteristics and outcomes of 1591 patients infected with sars co ...
Valentina Corona
crp as a prognostic indicator in hospitalized patient with covid 19
crp as a prognostic indicator in hospitalized patient with covid 19
tanjinamuntakim1
A trial of Lopinavir-Ritonavir in Adults Hospitalized with Sever COVID-19
A trial of Lopinavir-Ritonavir in Adults Hospitalized with Sever COVID-19
Valentina Corona
Clinical features of patients infected with 2019 novel copy
Clinical features of patients infected with 2019 novel copy
MadhumitaSingh23
Recommended
Asymptomatic Trasmission, the Achilles'Heel of Current Strategies to Control ...
Asymptomatic Trasmission, the Achilles'Heel of Current Strategies to Control ...
Valentina Corona
Mild or Moderete Covid-19
Mild or Moderete Covid-19
Valentina Corona
Hospital care in Department define as Covid-free: A proposal for a safe hospi...
Hospital care in Department define as Covid-free: A proposal for a safe hospi...
Valentina Corona
Journal clinical characteristics covid 19
Journal clinical characteristics covid 19
Shivaom Chaurasia
Baseline characteristics and outcomes of 1591 patients infected with sars co ...
Baseline characteristics and outcomes of 1591 patients infected with sars co ...
Valentina Corona
crp as a prognostic indicator in hospitalized patient with covid 19
crp as a prognostic indicator in hospitalized patient with covid 19
tanjinamuntakim1
A trial of Lopinavir-Ritonavir in Adults Hospitalized with Sever COVID-19
A trial of Lopinavir-Ritonavir in Adults Hospitalized with Sever COVID-19
Valentina Corona
Clinical features of patients infected with 2019 novel copy
Clinical features of patients infected with 2019 novel copy
MadhumitaSingh23
Respiratory virus shedding in exhaled breath and efficacy of face masks
Respiratory virus shedding in exhaled breath and efficacy of face masks
Valentina Corona
Clinical course and risk factors for mortality of adult inpatients with covid...
Clinical course and risk factors for mortality of adult inpatients with covid...
BARRY STANLEY 2 fasd
COVID-19: in gastroenterology a clinical perspective
COVID-19: in gastroenterology a clinical perspective
Valentina Corona
Caring for the critical patient
Caring for the critical patient
Valentina Corona
Jamainternal Internal Medicine
Jamainternal Internal Medicine
Valentina Corona
Operational Planning of Hospitals towards COVID 19 Pandemic- Indian Perspective
Operational Planning of Hospitals towards COVID 19 Pandemic- Indian Perspective
Lallu Joseph
PCR Assay Turned Positive in 25 Discharged COVID-19 Patients
PCR Assay Turned Positive in 25 Discharged COVID-19 Patients
Valentina Corona
Covid 19
Covid 19
omaralobaidy1
Coronavirus
Coronavirus
Thapar Institute of Engineering & Technology, Patiala, Punjab, India
Stepping Forward: Urologists' Effort During the COVID-19 Outbreak in Singapore
Stepping Forward: Urologists' Effort During the COVID-19 Outbreak in Singapore
Valentina Corona
Minimally invasive surgery and the novel coronavirus outbreak lessons learne...
Minimally invasive surgery and the novel coronavirus outbreak lessons learne...
Valentina Corona
Caring for patients with cancer in the COVID-19 era
Caring for patients with cancer in the COVID-19 era
Valentina Corona
Virtually Perfect? Telemedicine for Covid-19
Virtually Perfect? Telemedicine for Covid-19
Valentina Corona
Covid-19 Navigating the Uncharted
Covid-19 Navigating the Uncharted
Valentina Corona
Clinical features od severe pediatric patients with coronavirus disease 2019 ...
Clinical features od severe pediatric patients with coronavirus disease 2019 ...
Valentina Corona
Covid 19 & infertility
Covid 19 & infertility
Dr. Jyoti Malik
NOVEL THERAPEUTIC DRUG APPROACHES FOR COVID-19
NOVEL THERAPEUTIC DRUG APPROACHES FOR COVID-19
PARUL UNIVERSITY
Facing Covid-19 in Italy
Facing Covid-19 in Italy
Valentina Corona
The Shifting Landscape of Genitourinary Oncology During the Covid-19 Pandemi...
The Shifting Landscape of Genitourinary Oncology During the Covid-19 Pandemi...
Valentina Corona
COVID 19- Basics beyond Basics by Dr. Brij Teli
COVID 19- Basics beyond Basics by Dr. Brij Teli
doc2rock
Epidemiology of Covid-19 in a long-Term Care Facility in King County, Washington
Epidemiology of Covid-19 in a long-Term Care Facility in King County, Washington
Valentina Corona
Factores de riesgo para reingreso temprano despues de hospitalizacion por cov...
Factores de riesgo para reingreso temprano despues de hospitalizacion por cov...
MelendiNavarro
More Related Content
What's hot
Respiratory virus shedding in exhaled breath and efficacy of face masks
Respiratory virus shedding in exhaled breath and efficacy of face masks
Valentina Corona
Clinical course and risk factors for mortality of adult inpatients with covid...
Clinical course and risk factors for mortality of adult inpatients with covid...
BARRY STANLEY 2 fasd
COVID-19: in gastroenterology a clinical perspective
COVID-19: in gastroenterology a clinical perspective
Valentina Corona
Caring for the critical patient
Caring for the critical patient
Valentina Corona
Jamainternal Internal Medicine
Jamainternal Internal Medicine
Valentina Corona
Operational Planning of Hospitals towards COVID 19 Pandemic- Indian Perspective
Operational Planning of Hospitals towards COVID 19 Pandemic- Indian Perspective
Lallu Joseph
PCR Assay Turned Positive in 25 Discharged COVID-19 Patients
PCR Assay Turned Positive in 25 Discharged COVID-19 Patients
Valentina Corona
Covid 19
Covid 19
omaralobaidy1
Coronavirus
Coronavirus
Thapar Institute of Engineering & Technology, Patiala, Punjab, India
Stepping Forward: Urologists' Effort During the COVID-19 Outbreak in Singapore
Stepping Forward: Urologists' Effort During the COVID-19 Outbreak in Singapore
Valentina Corona
Minimally invasive surgery and the novel coronavirus outbreak lessons learne...
Minimally invasive surgery and the novel coronavirus outbreak lessons learne...
Valentina Corona
Caring for patients with cancer in the COVID-19 era
Caring for patients with cancer in the COVID-19 era
Valentina Corona
Virtually Perfect? Telemedicine for Covid-19
Virtually Perfect? Telemedicine for Covid-19
Valentina Corona
Covid-19 Navigating the Uncharted
Covid-19 Navigating the Uncharted
Valentina Corona
Clinical features od severe pediatric patients with coronavirus disease 2019 ...
Clinical features od severe pediatric patients with coronavirus disease 2019 ...
Valentina Corona
Covid 19 & infertility
Covid 19 & infertility
Dr. Jyoti Malik
NOVEL THERAPEUTIC DRUG APPROACHES FOR COVID-19
NOVEL THERAPEUTIC DRUG APPROACHES FOR COVID-19
PARUL UNIVERSITY
Facing Covid-19 in Italy
Facing Covid-19 in Italy
Valentina Corona
The Shifting Landscape of Genitourinary Oncology During the Covid-19 Pandemi...
The Shifting Landscape of Genitourinary Oncology During the Covid-19 Pandemi...
Valentina Corona
COVID 19- Basics beyond Basics by Dr. Brij Teli
COVID 19- Basics beyond Basics by Dr. Brij Teli
doc2rock
What's hot
(20)
Respiratory virus shedding in exhaled breath and efficacy of face masks
Respiratory virus shedding in exhaled breath and efficacy of face masks
Clinical course and risk factors for mortality of adult inpatients with covid...
Clinical course and risk factors for mortality of adult inpatients with covid...
COVID-19: in gastroenterology a clinical perspective
COVID-19: in gastroenterology a clinical perspective
Caring for the critical patient
Caring for the critical patient
Jamainternal Internal Medicine
Jamainternal Internal Medicine
Operational Planning of Hospitals towards COVID 19 Pandemic- Indian Perspective
Operational Planning of Hospitals towards COVID 19 Pandemic- Indian Perspective
PCR Assay Turned Positive in 25 Discharged COVID-19 Patients
PCR Assay Turned Positive in 25 Discharged COVID-19 Patients
Covid 19
Covid 19
Coronavirus
Coronavirus
Stepping Forward: Urologists' Effort During the COVID-19 Outbreak in Singapore
Stepping Forward: Urologists' Effort During the COVID-19 Outbreak in Singapore
Minimally invasive surgery and the novel coronavirus outbreak lessons learne...
Minimally invasive surgery and the novel coronavirus outbreak lessons learne...
Caring for patients with cancer in the COVID-19 era
Caring for patients with cancer in the COVID-19 era
Virtually Perfect? Telemedicine for Covid-19
Virtually Perfect? Telemedicine for Covid-19
Covid-19 Navigating the Uncharted
Covid-19 Navigating the Uncharted
Clinical features od severe pediatric patients with coronavirus disease 2019 ...
Clinical features od severe pediatric patients with coronavirus disease 2019 ...
Covid 19 & infertility
Covid 19 & infertility
NOVEL THERAPEUTIC DRUG APPROACHES FOR COVID-19
NOVEL THERAPEUTIC DRUG APPROACHES FOR COVID-19
Facing Covid-19 in Italy
Facing Covid-19 in Italy
The Shifting Landscape of Genitourinary Oncology During the Covid-19 Pandemi...
The Shifting Landscape of Genitourinary Oncology During the Covid-19 Pandemi...
COVID 19- Basics beyond Basics by Dr. Brij Teli
COVID 19- Basics beyond Basics by Dr. Brij Teli
Similar to Presynmptoms SARS-Cov-2 Infection and Transmission in Skilled Nursing Facility
Epidemiology of Covid-19 in a long-Term Care Facility in King County, Washington
Epidemiology of Covid-19 in a long-Term Care Facility in King County, Washington
Valentina Corona
Factores de riesgo para reingreso temprano despues de hospitalizacion por cov...
Factores de riesgo para reingreso temprano despues de hospitalizacion por cov...
MelendiNavarro
Hospital outbreak of middle east respiratory syndrome
Hospital outbreak of middle east respiratory syndrome
Dee Evardone
Nejmoa
Nejmoa
gisa_legal
Covid-19: state of art at 30.03.2020
Covid-19: state of art at 30.03.2020
Valentina Corona
Should All Patients Having Planned Procedures or Surgeries Be Tested for COVI...
Should All Patients Having Planned Procedures or Surgeries Be Tested for COVI...
JohnJulie1
Should All Patients Having Planned Procedures or Surgeries Be Tested for COVI...
Should All Patients Having Planned Procedures or Surgeries Be Tested for COVI...
suppubs1pubs1
Application of ordinal logistic=China.pdf
Application of ordinal logistic=China.pdf
HenokBuno
doi: 10.1101/2021.05.28.21258012
doi: 10.1101/2021.05.28.21258012
MattisHallsteinVolla
Review article
Review article
DrShanthiSabari
Farmacologia COVID Jama sanders 2020_rv_200005 Dr. Freddy Flores Malpartida
Farmacologia COVID Jama sanders 2020_rv_200005 Dr. Freddy Flores Malpartida
Freddy Flores Malpartida
Jama sanders 2020 tto
Jama sanders 2020 tto
Freddy Flores Malpartida
Covid 19-ppt
Covid 19-ppt
Nityant Singhal
The Gibraltar COVID-19 Cohort: Determining the True Incidence and Severity Ra...
The Gibraltar COVID-19 Cohort: Determining the True Incidence and Severity Ra...
asclepiuspdfs
1 jmv.27253.pdf
1 jmv.27253.pdf
Gizaw10
Coronavirus Disease (COVID)-19 Outbeak
Coronavirus Disease (COVID)-19 Outbeak
Tahseen Siddiqui
Jama sanders covid-19
Jama sanders covid-19
gisa_legal
Clinical Trials: Phase 1/2 Highlights
Clinical Trials: Phase 1/2 Highlights
Kumaraguru Veerasamy
Covid 19-book
Covid 19-book
imranndj
To Assess the Severity and Mortality among Covid 19 Patients after Having Vac...
To Assess the Severity and Mortality among Covid 19 Patients after Having Vac...
YogeshIJTSRD
Similar to Presynmptoms SARS-Cov-2 Infection and Transmission in Skilled Nursing Facility
(20)
Epidemiology of Covid-19 in a long-Term Care Facility in King County, Washington
Epidemiology of Covid-19 in a long-Term Care Facility in King County, Washington
Factores de riesgo para reingreso temprano despues de hospitalizacion por cov...
Factores de riesgo para reingreso temprano despues de hospitalizacion por cov...
Hospital outbreak of middle east respiratory syndrome
Hospital outbreak of middle east respiratory syndrome
Nejmoa
Nejmoa
Covid-19: state of art at 30.03.2020
Covid-19: state of art at 30.03.2020
Should All Patients Having Planned Procedures or Surgeries Be Tested for COVI...
Should All Patients Having Planned Procedures or Surgeries Be Tested for COVI...
Should All Patients Having Planned Procedures or Surgeries Be Tested for COVI...
Should All Patients Having Planned Procedures or Surgeries Be Tested for COVI...
Application of ordinal logistic=China.pdf
Application of ordinal logistic=China.pdf
doi: 10.1101/2021.05.28.21258012
doi: 10.1101/2021.05.28.21258012
Review article
Review article
Farmacologia COVID Jama sanders 2020_rv_200005 Dr. Freddy Flores Malpartida
Farmacologia COVID Jama sanders 2020_rv_200005 Dr. Freddy Flores Malpartida
Jama sanders 2020 tto
Jama sanders 2020 tto
Covid 19-ppt
Covid 19-ppt
The Gibraltar COVID-19 Cohort: Determining the True Incidence and Severity Ra...
The Gibraltar COVID-19 Cohort: Determining the True Incidence and Severity Ra...
1 jmv.27253.pdf
1 jmv.27253.pdf
Coronavirus Disease (COVID)-19 Outbeak
Coronavirus Disease (COVID)-19 Outbeak
Jama sanders covid-19
Jama sanders covid-19
Clinical Trials: Phase 1/2 Highlights
Clinical Trials: Phase 1/2 Highlights
Covid 19-book
Covid 19-book
To Assess the Severity and Mortality among Covid 19 Patients after Having Vac...
To Assess the Severity and Mortality among Covid 19 Patients after Having Vac...
More from Valentina Corona
Walter Artibani
Walter Artibani
Valentina Corona
Progetto strategico SIU Oltre
Progetto strategico SIU Oltre
Valentina Corona
Telehealth in Urology: A Systematic Review of the Literature.
Telehealth in Urology: A Systematic Review of the Literature.
Valentina Corona
Remdesivir for the Treatment of Covid-19
Remdesivir for the Treatment of Covid-19
Valentina Corona
Avoidng disruption of timely surgical management of genitourinary cancers ...
Avoidng disruption of timely surgical management of genitourinary cancers ...
Valentina Corona
Avoiding disruption of surgical treatment of genitourinary cancers...
Avoiding disruption of surgical treatment of genitourinary cancers...
Valentina Corona
A systematic review on COVID-1: urological manifestations...
A systematic review on COVID-1: urological manifestations...
Valentina Corona
Urology in the time of Coronavirus: Reduced Acmes to Urgent and Emergent Care...
Urology in the time of Coronavirus: Reduced Acmes to Urgent and Emergent Care...
Valentina Corona
Research Correspondence
Research Correspondence
Valentina Corona
Accessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Pr...
Accessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Pr...
Valentina Corona
A Global Survey on the Impact of COVID-19 on Urological Services
A Global Survey on the Impact of COVID-19 on Urological Services
Valentina Corona
Since January Elsevier has created a COVID-19 resource center with...
Since January Elsevier has created a COVID-19 resource center with...
Valentina Corona
Since January Elsevier has created a COVID-19 resource center with...
Since January Elsevier has created a COVID-19 resource center with...
Valentina Corona
Androgen-deprivation therapies for prostate cancer and risk of infection by S...
Androgen-deprivation therapies for prostate cancer and risk of infection by S...
Valentina Corona
Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces
Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces
Valentina Corona
Hydroxychloroquine or chloroquine with or without a macrolide for treatment o...
Hydroxychloroquine or chloroquine with or without a macrolide for treatment o...
Valentina Corona
Chloroquine or hydroxychloroquine for Covid-19: why might they be hazardous?
Chloroquine or hydroxychloroquine for Covid-19: why might they be hazardous?
Valentina Corona
Pulmonary Vascular Endotheliatis Thrombosis, and Angiogenesis in Covid-19
Pulmonary Vascular Endotheliatis Thrombosis, and Angiogenesis in Covid-19
Valentina Corona
Assessment of Deaths from Covid 19 and from Seasonal Influenza
Assessment of Deaths from Covid 19 and from Seasonal Influenza
Valentina Corona
Protocollo biopsie prostatiche fase 2
Protocollo biopsie prostatiche fase 2
Valentina Corona
More from Valentina Corona
(20)
Walter Artibani
Walter Artibani
Progetto strategico SIU Oltre
Progetto strategico SIU Oltre
Telehealth in Urology: A Systematic Review of the Literature.
Telehealth in Urology: A Systematic Review of the Literature.
Remdesivir for the Treatment of Covid-19
Remdesivir for the Treatment of Covid-19
Avoidng disruption of timely surgical management of genitourinary cancers ...
Avoidng disruption of timely surgical management of genitourinary cancers ...
Avoiding disruption of surgical treatment of genitourinary cancers...
Avoiding disruption of surgical treatment of genitourinary cancers...
A systematic review on COVID-1: urological manifestations...
A systematic review on COVID-1: urological manifestations...
Urology in the time of Coronavirus: Reduced Acmes to Urgent and Emergent Care...
Urology in the time of Coronavirus: Reduced Acmes to Urgent and Emergent Care...
Research Correspondence
Research Correspondence
Accessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Pr...
Accessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Pr...
A Global Survey on the Impact of COVID-19 on Urological Services
A Global Survey on the Impact of COVID-19 on Urological Services
Since January Elsevier has created a COVID-19 resource center with...
Since January Elsevier has created a COVID-19 resource center with...
Since January Elsevier has created a COVID-19 resource center with...
Since January Elsevier has created a COVID-19 resource center with...
Androgen-deprivation therapies for prostate cancer and risk of infection by S...
Androgen-deprivation therapies for prostate cancer and risk of infection by S...
Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces
Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces
Hydroxychloroquine or chloroquine with or without a macrolide for treatment o...
Hydroxychloroquine or chloroquine with or without a macrolide for treatment o...
Chloroquine or hydroxychloroquine for Covid-19: why might they be hazardous?
Chloroquine or hydroxychloroquine for Covid-19: why might they be hazardous?
Pulmonary Vascular Endotheliatis Thrombosis, and Angiogenesis in Covid-19
Pulmonary Vascular Endotheliatis Thrombosis, and Angiogenesis in Covid-19
Assessment of Deaths from Covid 19 and from Seasonal Influenza
Assessment of Deaths from Covid 19 and from Seasonal Influenza
Protocollo biopsie prostatiche fase 2
Protocollo biopsie prostatiche fase 2
Recently uploaded
Top Rated Hyderabad Call Girls Chintal ⟟ 9332606886 ⟟ Call Me For Genuine Se...
Top Rated Hyderabad Call Girls Chintal ⟟ 9332606886 ⟟ Call Me For Genuine Se...
chandars293
Call Girls Mumbai Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Mumbai Just Call 8250077686 Top Class Call Girl Service Available
Dipal Arora
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
Sheetaleventcompany
Top Rated Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...
Top Rated Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...
chandars293
Top Rated Call Girls Kerala ☎ 8250092165👄 Delivery in 20 Mins Near Me
Top Rated Call Girls Kerala ☎ 8250092165👄 Delivery in 20 Mins Near Me
chennailover
Call Girls Varanasi Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 8250077686 Top Class Call Girl Service Available
Dipal Arora
Top Rated Pune Call Girls (DIPAL) ⟟ 8250077686 ⟟ Call Me For Genuine Sex Serv...
Top Rated Pune Call Girls (DIPAL) ⟟ 8250077686 ⟟ Call Me For Genuine Sex Serv...
Dipal Arora
Coimbatore Call Girls in Thudiyalur : 7427069034 High Profile Model Escorts |...
Coimbatore Call Girls in Thudiyalur : 7427069034 High Profile Model Escorts |...
chennailover
Independent Call Girls Service Mohali Sector 116 | 6367187148 | Call Girl Ser...
Independent Call Girls Service Mohali Sector 116 | 6367187148 | Call Girl Ser...
karishmasinghjnh
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
mahaiklolahd
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Ishani Gupta
Call Girls Rishikesh Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 8250077686 Top Class Call Girl Service Available
Dipal Arora
Kollam call girls Mallu aunty service 7877702510
Kollam call girls Mallu aunty service 7877702510
Vipesco
Models Call Girls In Hyderabad 9630942363 Hyderabad Call Girl & Hyderabad Esc...
Models Call Girls In Hyderabad 9630942363 Hyderabad Call Girl & Hyderabad Esc...
GENUINE ESCORT AGENCY
8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
GENUINE ESCORT AGENCY
Call Girls in Lucknow Just Call 👉👉7877925207 Top Class Call Girl Service Avai...
Call Girls in Lucknow Just Call 👉👉7877925207 Top Class Call Girl Service Avai...
adilkhan87451
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
parulsinha
Call Girls Kolkata Kalikapur 💯Call Us 🔝 8005736733 🔝 💃 Top Class Call Girl Se...
Call Girls Kolkata Kalikapur 💯Call Us 🔝 8005736733 🔝 💃 Top Class Call Girl Se...
Namrata Singh
Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...
Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...
khalifaescort01
Coimbatore Call Girls in Coimbatore 7427069034 genuine Escort Service Girl 10...
Coimbatore Call Girls in Coimbatore 7427069034 genuine Escort Service Girl 10...
chennailover
Recently uploaded
(20)
Top Rated Hyderabad Call Girls Chintal ⟟ 9332606886 ⟟ Call Me For Genuine Se...
Top Rated Hyderabad Call Girls Chintal ⟟ 9332606886 ⟟ Call Me For Genuine Se...
Call Girls Mumbai Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Mumbai Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
Top Rated Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...
Top Rated Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...
Top Rated Call Girls Kerala ☎ 8250092165👄 Delivery in 20 Mins Near Me
Top Rated Call Girls Kerala ☎ 8250092165👄 Delivery in 20 Mins Near Me
Call Girls Varanasi Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 8250077686 Top Class Call Girl Service Available
Top Rated Pune Call Girls (DIPAL) ⟟ 8250077686 ⟟ Call Me For Genuine Sex Serv...
Top Rated Pune Call Girls (DIPAL) ⟟ 8250077686 ⟟ Call Me For Genuine Sex Serv...
Coimbatore Call Girls in Thudiyalur : 7427069034 High Profile Model Escorts |...
Coimbatore Call Girls in Thudiyalur : 7427069034 High Profile Model Escorts |...
Independent Call Girls Service Mohali Sector 116 | 6367187148 | Call Girl Ser...
Independent Call Girls Service Mohali Sector 116 | 6367187148 | Call Girl Ser...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Call Girls Rishikesh Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 8250077686 Top Class Call Girl Service Available
Kollam call girls Mallu aunty service 7877702510
Kollam call girls Mallu aunty service 7877702510
Models Call Girls In Hyderabad 9630942363 Hyderabad Call Girl & Hyderabad Esc...
Models Call Girls In Hyderabad 9630942363 Hyderabad Call Girl & Hyderabad Esc...
8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
Call Girls in Lucknow Just Call 👉👉7877925207 Top Class Call Girl Service Avai...
Call Girls in Lucknow Just Call 👉👉7877925207 Top Class Call Girl Service Avai...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
Call Girls Kolkata Kalikapur 💯Call Us 🔝 8005736733 🔝 💃 Top Class Call Girl Se...
Call Girls Kolkata Kalikapur 💯Call Us 🔝 8005736733 🔝 💃 Top Class Call Girl Se...
Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...
Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...
Coimbatore Call Girls in Coimbatore 7427069034 genuine Escort Service Girl 10...
Coimbatore Call Girls in Coimbatore 7427069034 genuine Escort Service Girl 10...
Presynmptoms SARS-Cov-2 Infection and Transmission in Skilled Nursing Facility
1.
The new engl
and jour nal of medicine n engl j med nejm.org 1 The authors’ full names, academic de- grees, and affiliations are listed in the Ap- pendix. Address reprint requests to Dr. Jernigan at the Centers for Disease Con- trol and Prevention, 1600 Clifton Rd., Mailstop A-31, Atlanta, GA 30333, or at jqj9@cdc.gov. *A complete list of the investigators is in- cluded in the Supplementary Appendix, available at NEJM.org. Ms. Arons and Ms. Hatfield contributed equally to this article. This article was published on April 24, 2020, at NEJM.org. DOI: 10.1056/NEJMoa2008457 Copyright © 2020 Massachusetts Medical Society. BACKGROUND Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can spread rapidly within skilled nursing facilities. After identification of a case of Covid-19 in a skilled nursing facility, we assessed transmission and evaluated the adequacy of symptom-based screening to identify infections in residents. METHODS We conducted two serial point-prevalence surveys, 1 week apart, in which assenting residents of the facility underwent nasopharyngeal and oropharyngeal testing for SARS-CoV-2, including real-time reverse-transcriptase polymerase chain reaction (rRT-PCR), viral culture, and sequencing. Symptoms that had been present during the preceding 14 days were recorded. Asymptomatic residents who tested positive were reassessed 7 days later. Residents with SARS-CoV-2 infection were catego- rized as symptomatic with typical symptoms (fever, cough, or shortness of breath), symptomatic with only atypical symptoms, presymptomatic, or asymptomatic. RESULTS Twenty-three days after the first positive test result in a resident at this skilled nurs- ing facility, 57 of 89 residents (64%) tested positive for SARS-CoV-2. Among 76 resi- dents who participated in point-prevalence surveys, 48 (63%) tested positive. Of these 48 residents, 27 (56%) were asymptomatic at the time of testing; 24 subsequently developed symptoms (median time to onset, 4 days). Samples from these 24 pre- symptomatic residents had a median rRT-PCR cycle threshold value of 23.1, and viable virus was recovered from 17 residents. As of April 3, of the 57 residents with SARS-CoV-2 infection, 11 had been hospitalized (3 in the intensive care unit) and 15 had died (mortality, 26%). Of the 34 residents whose specimens were sequenced, 27 (79%) had sequences that fit into two clusters with a difference of one nucleotide. CONCLUSIONS Rapid and widespread transmission of SARS-CoV-2 was demonstrated in this skilled nursing facility. More than half of residents with positive test results were asymp- tomatic at the time of testing and most likely contributed to transmission. Infec- tion-control strategies focused solely on symptomatic residents were not sufficient to prevent transmission after SARS-CoV-2 introduction into this facility. ABSTR ACT Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility M.M. Arons, K.M. Hatfield, S.C. Reddy, A. Kimball, A. James, J.R. Jacobs, J. Taylor, K. Spicer, A.C. Bardossy, L.P. Oakley, S. Tanwar, J.W. Dyal, J. Harney, Z. Chisty, J.M. Bell, M. Methner, P. Paul, C.M. Carlson, H.P. McLaughlin, N. Thornburg, S. Tong, A. Tamin, Y. Tao, A. Uehara, J. Harcourt, S. Clark, C. Brostrom‑Smith, L.C. Page, M. Kay, J. Lewis, P. Montgomery, N.D. Stone, T.A. Clark, M.A. Honein, J.S. Duchin, and J.A. Jernigan, for the Public Health–Seattle and King County and CDC COVID-19 Investigation Team* Original Article The New England Journal of Medicine Downloaded from nejm.org by ROD STER on April 24, 2020. For personal use only. No other uses without permission. Copyright © 2020 Massachusetts Medical Society. All rights reserved.
2.
n engl j
med nejm.org2 The new engl and jour nal of medicine T he first reported case of coronavi- rus disease 2019 (Covid-19) in the United States was diagnosed in a resident of Sno- homish County, Washington, on January 20, 2020.1 In late February, an outbreak was identified in a skilled nursing facility in neighboring King Coun- ty; morbidity and mortality among residents were high, straining the regional health care system.2,3 We report another outbreak of Covid-19 in a separate skilled nursing facility in the same county. In the course of this outbreak investigation, Pub- lic Health–Seattle and King County (PHSKC) and the Centers for Disease Control and Prevention (CDC) identified residents with asymptomatic SARS-CoV-2 infection, which prompted further investigation. We performed serial point-preva- lence surveys to assess the extent of transmission and to evaluate the adequacy of symptom-based screening of residents to identify infections. Ini- tial findings of this investigation were previously reported.4 Description of the Outbreak On February 29, 2020, in response to increased local awareness of Covid-19 in King County, Washington, administrative leadership at Facility A instituted enhanced infection-control measures. Nursing staff assessed residents twice daily for possible signs and symptoms of Covid-19, includ- ing fever (oral or temporal temperature mea- surement), cough, shortness of breath, and other symptoms. Health care personnel were assessed at the start of each shift with oral temperature measurement and screening for symptoms, in- cluding cough, shortness of breath, sore throat, or any other respiratory symptoms. On March 1, one member of the health care staff tested positive for SARS-CoV-2 after having worked in a single unit (Unit 1) while symptom- atic on February 26, the first day of symptoms, and on February 28. On March 5, the facility was informed that a hospitalized resident of Unit 1 (in whom symptoms had developed on March 2 and testing was done on March 3) had been di- agnosed with Covid-19. Subsequently, all visitors were restricted and communal activities were can- celed. PHSKC and the CDC initiated an outbreak investigation, and on March 6, provided on-site infection prevention and control recommenda- tions, including the recommendation that all health care staff entering symptomatic residents’ rooms wear eye protection, a gown, gloves, and a face mask (N95 respirators were not routinely available).5 On March 8, the CDC and PHSKC offered testing to all residents in Unit 1; 13 of 15 residents present were tested for SARS-CoV-2 (2 residents declined). A total of 6 residents tested positive; of these, 4 had symptoms (e.g., fever, cough, shortness of breath, or sore throat) and 2 had been asymptomatic during the preceding 14 days. On March 9, the facility implemented Covid-19 transmission-based precautions for all residents of Unit 1, regardless of symptoms or infection status. Methods Study Population Facility A is a 116-bed skilled nursing facility di- vided into four separate units with an equal mix of short- and long-term residents in each unit. There were 89 residents present at Facility A on March 3, the date of the first positive test in a resident. Facil- ity A provided a list of full-time health care person- nel by occupation. Results of positive SARS-CoV-2 tests obtained during postmortem examination or by outside health care providers during clinical evaluation of symptomatic residents and staff were provided to the CDC and PHSKC through March 26. All symptomatic health care personnel were advised to be tested by their health care provider; asymptomatic staff members were not tested as part of this investigation. Point-Prevalence Surveys On two occasions, residents in the facility were offered SARS-CoV-2 testing as part of a facility- wide point-prevalence survey. The first survey was performed for all assenting residents, including those who had previously tested positive, on March 13 (10 days after the first resident had tested positive for SARS-CoV-2). Nasopharyngeal and oropharyngeal swabs were collected in accordance with CDC guidelines.6 A second survey was con- ducted 7 days later (March 19–20) for residents who had had either a negative test result or a positive result with atypical or no symptoms re- ported in the first survey. Symptom Assessment On the day of point-prevalence surveys, a standard- ized symptom-assessment form was completed by nurses for each resident tested. Symptoms pres- The New England Journal of Medicine Downloaded from nejm.org by ROD STER on April 24, 2020. For personal use only. No other uses without permission. Copyright © 2020 Massachusetts Medical Society. All rights reserved.
3.
n engl j
med nejm.org 3 Presymptomatic SARS-CoV-2 in a Nursing Facility ent during the preceding 14 days were recorded on the basis of interview and review of medical re- cords. Asymptomatic residents with a positive test result were reassessed for symptoms 7 days later. For additional details on symptom assessment, see the Supplementary Appendix, available with the full text of this article at NEJM.org. Residents were classified as symptomatic if they had had at least one new or worsened typi- cal or atypical symptom of Covid-19 in the pre- ceding 14 days. Residents with subjective fever or temperature greater than 100.0°F (37.8°C), cough, or shortness of breath were classified as symptomatic with typical symptoms.7 Residents were classified as symptomatic with atypical symp- toms if their symptoms included only chills, mal- aise, increased confusion, rhinorrhea, nasal con- gestion, sore throat, myalgia, dizziness, headache, nausea, or diarrhea. Asymptomatic residents were those who had no symptoms or only stable chronic symptoms (e.g., chronic cough without worsening). Pres- ymptomatic residents were those who were as- ymptomatic at the time of testing but developed symptoms within 7 days after testing. Residents who did not develop symptoms in the 7 days after testing remained classified as asymptomatic. Laboratory Testing The Washington State Public Health Laboratory performed one-step real-time reverse transcrip- tase–polymerase chain reaction (rRT-PCR) on all samples, using the SARS-CoV-2 CDC assay pro- tocol; cycle threshold (Ct) values were reported for two genetic markers: the N1 and N2 viral nucleocapsid protein gene regions.8,9 Values below 40 cycles indicate a positive result for SARS-CoV-2. All rRT-PCR–positive specimens from point- prevalence surveys were shipped to the CDC for viral culture using Vero-CCL-81 cells. Cells show- ing cytopathic effect were used for SARS-CoV-2 rRT-PCR to confirm isolation and viral growth in culture. Nucleic acid was extracted from rRT-PCR– positive specimens and amplified for subsequent sequencing (Oxford Nanopore MinION), with phy- logenetic trees inferred with the neighbor-joining method.10 Additional details on culture and se- quencing methods are provided in the Supplemen- tary Appendix. Analyses The daily proportions of residents with any known positive test for SARS-CoV-2 (including those tested as part of clinical management) were described according to their unit in the facility. The daily growth rate for the facility was estimated through regression analysis, using the log-transformed daily cumulative counts of all residents who were positive for SARS-CoV-2 from March 3 through March 20; doubling time was estimated by divid- ing the natural logarithm of 2 by the growth rate. Similarly, doubling time was estimated for all residents of King County, using case count data reported through the PHSKC Covid-19 data dashboard.11 All analyses were completed with SAS soft- ware, version 9.4 (SAS Institute). Data were collected as part of public health response and were deemed non–human subjects research by the CDC. Results Residents Of the 89 residents who lived in Facility A when the first resident with confirmed Covid-19 was tested, 57 (64%) had tested positive for SARS- CoV-2 either during the point-prevalence surveys, clinical evaluation, or postmortem examination as of March 26. Seventy-six residents participat- ed in the first point-prevalence survey on March 13 (Fig. 1). Of these 76 residents, 48 (63%) tested positive in either the initial or subsequent point- prevalence surveys. Demographic characteristics, coexisting conditions, and symptoms of surveyed residents were similar, regardless of test result (Table 1). Of the 48 residents who tested positive from the surveys, 17 (35%) reported typical symptoms, 4 (8%) reported only atypical symptoms, and 27 (56%) reported no new symptoms or changes in chronic symptoms at the time of testing (Table 1 and Table S1). Among the 27 residents classified as asymptomatic, 15 reported no symptoms and 12 reported only stable chronic symptoms. Fif- teen (56%) residents who were asymptomatic at the time of testing had documented cognitive impairment; similar proportions were reported in symptomatic residents (Table S2). In the 7 days after their positive test, 24 of the 27 asymptomatic residents (89%) had onset of symptoms and were recategorized as presymp- tomatic. The median time to symptom onset was 4 days (interquartile range, 3 to 5). The most com- mon new symptoms were fever (71%), cough (54%), and malaise (42%) (Table S3). The New England Journal of Medicine Downloaded from nejm.org by ROD STER on April 24, 2020. For personal use only. No other uses without permission. Copyright © 2020 Massachusetts Medical Society. All rights reserved.
4.
n engl j
med nejm.org4 The new engl and jour nal of medicine 76WeretestedonMarch13 89ResidentsofFacilityAonMarch3 6Werehospitalized(alltestedpositiveforSARS-CoV-2inhospital) 1Wasdischargedhome 23Werepositive 1Whopreviouslytested positivewasnegative 1Hadtypicalsymptoms 52Werenegative 49Wereretested March19–20 12Wereasymp- tomatic 9Hadtypical symptoms 2Hadatypical symptoms 15Wereasymp- tomatic 7Hadtypical symptoms 2Wereasymp- tomatic 13Werepre- symptomatic 2Hadatypical symptoms 1Wasasymp- tomatic 11Werepre- symptomatic 24Werepositive25Werenegative 82ResidentsonMarch13 2Werehospitalizedbeforetesting(bothwerefoundtobepositive duringhospitalization) 1Didnothavedataavailable 3Declinedtobetested(1foundtobepositivepostmortem) 3Leftfacilitybefore March19 The New England Journal of Medicine Downloaded from nejm.org by ROD STER on April 24, 2020. For personal use only. No other uses without permission. Copyright © 2020 Massachusetts Medical Society. All rights reserved.
5.
n engl j
med nejm.org 5 Presymptomatic SARS-CoV-2 in a Nursing Facility Cycle Threshold and Viral Culture rRT-PCR Ct values for the N1 genetic markers for 47 residents ranged from 13.7 to 37.9; median Ct values for the four symptom status groups were similar (asymptomatic residents, 25.5; presymp- tomatic residents, 23.1; residents with atypical symptoms, 24.2; and residents with typical symp- toms, 24.8) (Fig. 2). SARS-CoV-2 growth was iden- tified from 31 of 46 rRT-PCR–positive specimens (Fig. 2). Viral growth was observed for specimens obtained from 10 of 16 residents with typical symptoms, 3 of 4 with atypical symptoms, 17 of Figure 1 (facing page). Residents in Facility A on March 3 through Two Point-Prevalence Surveys. Shown are all 89 residents who lived in skilled nursing facility A from March 3, when the first resident tested positive for SARS-CoV-2. By March 13, the date of the first point-prevalence survey, 82 residents remained in the facility, and 76 were tested. By the second point- prevalence survey, 48 of the 76 residents tested in the point-prevalence surveys had been identified as posi- tive. Overall, 57 residents were positive as of March 26. Cycle threshold values were available for 47 residents who tested positive in the point-prevalence surveys on March 13 and March 19–20. Table 1. Demographic Characteristics and Reported Symptoms in Residents of Facility A at the Time of Testing.* Characteristics SARS-CoV-2 Test Results Positive† (N = 48) Negative‡ (N = 28) Overall Positive result during initial facility-wide cohort testing — no. (%) 23 (48) — Mean age (±SD) — yr 78.6±9.5 73.8±11.5 Length of stay at Facility A <90 days before testing — no. (%) 23 (48) 14 (50) Coexisting conditions — no. (%) Any coexisting condition 47 (98) 28 (100) Chronic lung disease 18 (38) 8 (29) Diabetes 18 (38) 11 (39) Cardiovascular disease 39 (81) 17 (61) Cerebrovascular accident 19 (40) 8 (29) Renal disease 18 (38) 9 (32) Received hemodialysis 3 (6) 1 (4) Cognitive impairment 28 (58) 13 (46) Obesity 11 (23) 6 (21) Symptoms during the past 14 days — no. (%) In symptomatic residents§ 21 (44) 11 (39) At least one typical Covid-19 symptom 17 (35) 8 (29) Only atypical Covid-19 symptoms 4 (8) 3 (11) In asymptomatic residents 27 (56) 18 (64) No symptoms 15 (31) 14 (50) Only stable, chronic symptoms 12 (25) 3 (11) * Results include all residents who were present in the facility on March 13 and assented to screening. Facility-wide co- hort symptom screens and point-prevalence surveys were performed on March 13 and March 19–20, 2020. † Residents categorized as positive include those with at least one positive test from facility-wide point-prevalence sur- veys on March 13 or March 19–20 and one resident who tested negative on March 13 but tested positive before March 13. ‡ Residents categorized as negative include 3 residents who had only one negative swab on March 13 and were not re- tested. § Typical symptoms include fever, cough, and shortness of breath. Atypical symptoms include chills, malaise, sore throat, increased confusion, rhinorrhea or nasal congestion, myalgia, dizziness, headache, nausea, and diarrhea. The New England Journal of Medicine Downloaded from nejm.org by ROD STER on April 24, 2020. For personal use only. No other uses without permission. Copyright © 2020 Massachusetts Medical Society. All rights reserved.
6.
n engl j
med nejm.org6 The new engl and jour nal of medicine 24 who were presymptomatic, and 1 of 3 who remained asymptomatic. We observed no correlation between Ct values and the number of days from the first evidence of typical symptoms. Ct values consistent with a high viral load were identified among residents who tested positive before typical symptom on- set (median Ct value among 26 observations, 24.0; interquartile range, 20.4 to 28.5) and those who tested positive 7 or more days after typical symptom onset (median Ct value among 8 obser- vations, 25.0; interquartile range, 21.3 to 28.2) (Fig. 3, and Fig. S1). Viable virus was isolated from specimens collected 6 days before to 9 days after the first evidence of typical symptoms. Prevalence and Transmission in the Facility We estimated the doubling time among residents to be 3.4 days (95% confidence interval [CI], 2.5 to 5.3) (Table S4). The doubling time for the sur- rounding King County was 5.5 days (95% CI, 4.8 to 6.7). As of April 3, a total of 11 of the 57 resi- dents with SARS-CoV-2 infection identified by March 26 had been admitted to the hospital (in- cluding 3 in intensive care) and 15 had died (mor- tality, 26%). The unit where presumed introduc- tion of infection took place and where the first resident with SARS-CoV-2 infection lived (Unit 1) had the highest prevalence in the facility at the end of the first point-prevalence survey. Although other units identified SARS-CoV-2 infection in residents later, their prevalence also continued to increase (Fig. 4, and Fig. S4). By the time of the first point-prevalence sur- vey, 11 of 138 full-time staff members (8%) had had a positive test for SARS-CoV-2. By March 26, Figure 2. Cycle Threshold Values and Results of Viral Culture for Residents with Positive SARS-CoV-2 Tests According to Their Symptom Status. Shown are N1 target cycle threshold values and viral culture results for 47 residents’ first positive test for SARS-CoV-2 stratified by the resident’s symptom status at the time of the test. One positive test was not assessed for culture growth. Typical symptoms include fever, cough, and shortness of breath; atypical symptoms include chills, malaise, increased confusion, rhinorrhea or nasal congestion, myalgia, dizziness, headache, nausea, and diarrhea. 10 15 20 25 30 35 40 Cycle Threshold Values for N1 Target Positive culture Negative culture No culture Typical Symptoms (N=16) Atypical Symptoms (N=4) Presymptomatic (N=24) Asymptomatic (N=3) Figure 3. Cycle Threshold Values Relative to First Evidence of Fever, Cough, or Shortness of Breath. Shown are N1 target cycle threshold values and viral culture results for each resident’s positive tests for SARS-CoV-2 shown by day since the first evidence of fever, cough, or shortness of breath (N=55). Dates of onset of typical symp- toms were known for 43 residents; 12 residents with two specimens that were positive for SARS-CoV-2 are also in- cluded. One positive test was not assessed for culture growth. The relationship between the first test and the sec- ond test for residents who had two positive tests is shown in Figure S2. −9 −8 −7 −6 −5 −4 −3 −2 −1 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Days from First Evidence of Fever, Cough, or Shortness of Breath CycleThresholdValuesforN1Target 15 10 20 25 35 30 40 No culturePositive culture Negative culture The New England Journal of Medicine Downloaded from nejm.org by ROD STER on April 24, 2020. For personal use only. No other uses without permission. Copyright © 2020 Massachusetts Medical Society. All rights reserved.
7.
n engl j
med nejm.org 7 Presymptomatic SARS-CoV-2 in a Nursing Facility a total of 55 of the 138 (40%) had reported symp- toms, 51 (37%) had been tested, and 26 (19%) had received a positive test result. Of the 26 staff mem- bers with positive tests, 17 were nursing staff and 9 had occupations that provided services across multiple units during their shift (therapists, en- vironmental services, dietary services). No staff members with Covid-19 were hospitalized. Thirty-nine specimens from 34 residents were sequenced. All sequences were identical or high- ly similar to sequences reported in previous analy- ses of Covid-19 cases in Washington (Fig. S3). Of the 34 residents whose specimens were sequenced, 27 (79%) had sequences that fit into two clus- ters with one nucleotide difference (Fig. S4 and Table S5). Discussion Twenty-three days after identifying the first resi- dent with SARS-CoV-2 infection, Facility A had a 64% prevalence of Covid-19 among residents, with a case fatality rate of 26% despite early adoption of infection-control measures. In addition, Covid-19 was diagnosed in 26 members of the staff (19%). These findings are strikingly similar to descrip- tions of the first Covid-19 outbreak in a U.S. skilled nursing facility, which occurred in the same county at nearly the same time.2 In the investiga- tion reported here, more than half of the residents with positive tests were asymptomatic at the time of testing. Transmission from asymptomatic resi- dents infected with SARS-CoV-2 most likely contributed to the rapid and extensive spread of infection to other residents and staff. Symptom- based infection-control strategies were not suf- ficient to prevent transmission after the intro- duction of SARS-CoV-2 into this skilled nursing facility. Although we are unable to quantify the con- tributions of asymptomatic and presymptomatic residents to transmission of SARS-CoV-2 in this facility, evidence suggests that these residents had the potential for substantial viral shedding. Figure 4. Timeline Showing Prevalence, Notable Events, and Implementation of Infection Prevention and Control Measures at Facility A. Dashed lines indicate the prevalence of Covid-19 based on test results obtained during clinical evaluation of symptomatic residents be- fore a unit-wide or facility-wide point-prevalence survey (PPS); the dotted line indicates the prevalence based on results from a unit-spe- cific point-prevalence survey; and solid lines indicate the prevalence based on results from clinical evaluation and a facility-wide point- prevalence survey. PPE denotes personal protective equipment. PercentageofResidentsPositive forSARS-CoV-2 100 80 90 70 60 40 30 10 50 20 0 Feb.25Feb.26Feb.27Feb.28Feb.29M arch 1M arch 2M arch 3M arch 4M arch 5M arch 6M arch 7M arch 8M arch 9M arch 10M arch 11M arch 12M arch 13M arch 14M arch 15M arch 16M arch 17M arch 18M arch 19M arch 20 Unit 1 Unit 2 Unit 3 Unit 4 Total Suspected introduction of SARS-CoV-2 from symptomatic health care personnel in Unit 1. Temperature and Covid-19 symptom screening implemented for all residents and staff members. Unit-wide testing in Unit 1. Covid-19–recommended PPE implemented for all of Unit 1. Notification of PPS test results. Covid-19–recom- mended PPE imple- mented in all units. Notification of first positive test result in resident. Covid-19–recommended PPE implemented for symptomatic residents. Communal events canceled and visitors restricted. Initial facility- wide point- prevalence survey. Follow-up point- prevalence survey. The New England Journal of Medicine Downloaded from nejm.org by ROD STER on April 24, 2020. For personal use only. No other uses without permission. Copyright © 2020 Massachusetts Medical Society. All rights reserved.
8.
n engl j
med nejm.org8 The new engl and jour nal of medicine Ct values indicating large quantities of viral RNA were identified, and viable SARS-CoV-2 was isolated from specimens of asymptomatic and presymptomatic residents. Evidence of transmis- sion from presymptomatic persons has been shown in epidemiologic investigations of SARS- CoV-2.12-14 We estimated that the doubling time in this facility was 3.4 days, which is faster than that of the surrounding community, 5.5 days. The ac- celerated doubling time was likely to have been due to inadequately controlled intrafacility trans- mission, which sequencing and spatiotemporal data suggest was the primary driver of new in- fections. Shedding of high viral titers from the respiratory tract, including shedding before the onset of symptoms, might have led to droplet and possibly aerosol transmission. Residents and staff members with undetected SARS-CoV-2 infection are likely to have contributed to transmission through interactions between and among resi- dents and staff. The contribution of indirect con- tact transmission in this outbreak is not known. However, contaminated environmental surfaces and shared medical devices could also have played a role. Most of the early transmission ap- peared to have occurred in Unit 1, where the ini- tial introduction of SARS-CoV-2 took place, sev- eral days before other units were involved. Early recognition of initial SARS-CoV-2 introduction combined with early interventions in all units might prevent spread within a facility. The CDC and PHSKC confirmed Covid-19 infection in 26 symptomatic staff members as- sociated with this skilled nursing facility as of March 26; these staff members most likely con- tributed to intrafacility transmission. A concur- rent study of King County health care personnel with Covid-19 showed that 65% worked while symptomatic and that 17% of symptomatic health care personnel initially had mild, nonspe- cific symptoms and no fever, cough, shortness of breath, or sore throat.15 The potential for viral shedding from staff members with SARS-CoV-2 infection during either the presymptomatic or the mildly symptomatic phase of the illness re- inforces current recommendations for expanded symptom screening for health care personnel and universal use of face masks for all health care staff in long-term care facilities.5 Current interventions for preventing SARS- CoV-2 transmission in health care settings rely primarily on the presence of signs and symp- toms to identify and isolate residents and staff who might have Covid-19. The data presented here suggest that sole reliance on symptom- based strategies may not be effective to prevent introduction of SARS-CoV-2 and further trans- mission in skilled nursing facilities. Impaired immune responses associated with aging and the high prevalence of underlying conditions, such as cognitive impairment and chronic cough, make it difficult to recognize early signs and symptoms of respiratory viral infections in this population.16 Studies have shown that in the el- derly, including those living in skilled nursing facilities, influenza often manifests with few or atypical symptoms, delaying diagnosis and con- tributing to transmission.17,18 Furthermore, symp- tom-based cohorting strategies could inadver- tently increase the risk of SARS-CoV-2 exposure for uninfected residents, given that typical symp- toms were common in those who tested negative. Our investigation demonstrated a poor cor- relation between symptom onset and viral shed- ding that was potentially due to the difficulty of ascertaining precise dates of symptom onset or to differences in viral shedding in this population. Studies in other populations show that SARS- CoV-2 shedding is highest early in the illness.19,20 Our investigation shows that some facility resi- dents shed virus for more than 7 days after symptom onset, a finding seen in some other populations.21 These data support current rec- ommendations preferring a test-based strategy to discontinue transmission-based precautions for residents of skilled nursing facilities.22 If a non– test-based strategy is used, these data support extending the duration of transmission-based precautions.22 Because asymptomatic or presymptomatic residents might play an important role in trans- mission in this high-risk population, additional prevention measures merit consideration, includ- ing using testing to guide the use of transmis- sion-based precautions, isolation, and cohort- ing strategies. The ability to test large numbers of residents and staff with rapid turn-around times may expedite cohorting of residents and staff in locations designated for the care of those with SARS-CoV-2 infection either in different locations within individual facilities or in separate facilities. This investigation has several limitations. First, challenges in symptom ascertainment may The New England Journal of Medicine Downloaded from nejm.org by ROD STER on April 24, 2020. For personal use only. No other uses without permission. Copyright © 2020 Massachusetts Medical Society. All rights reserved.
9.
n engl j
med nejm.org 9 Presymptomatic SARS-CoV-2 in a Nursing Facility have resulted in misclassification of symptom grouping for some residents. However, multiple sources of symptom data were used to minimize such misclassification. The accuracy of symptom ascertainment for this investigation is likely to be equivalent to, if not exceed, symptom screen- ing in most skilled nursing facilities, and thus, these findings should be generalizable to this set- ting. Second, because this analysis was conducted among residents of a skilled nursing facility, it is not known whether the findings apply to the general population, including younger persons, those without underlying medical conditions, or similarly aged populations in the general com- munity or in other long-term care settings. Third, asymptomatic staff members were not tested; therefore, we are unable to document their role in transmission in this facility. SARS-CoV-2 can spread rapidly after introduc- tion into skilled nursing facilities, resulting in substantial morbidity and mortality and increas- ing the burden on regional health care systems. Unrecognized asymptomatic and presymptomatic infections most likely contribute to transmission in these settings. During the current Covid-19 pandemic, skilled nursing facilities and all long- term care facilities should take proactive steps to prevent introduction of SARS-CoV-2. These steps include restricting visitors and nonessential per- sonnel from entering the building, requiring universal use of face masks by all staff for source control while in the facility, and implementing strict screening of staff. Our data suggest that symptom-based strategies for identifying residents with SARS-CoV-2 are insufficient for preventing transmission in skilled nursing facilities. Once SARS-CoV-2 has been introduced, additional strate- gies should be implemented to prevent further transmission, including use of recommended per- sonal protective equipment, when available, during all resident care activities regardless of symptoms.5 Consideration should be given to test-based strate- gies for identifying residents and staff with SARS- CoV-2 infection for the purpose of excluding in- fected staff and cohorting residents, either in designated units within a facility or in a separate facility designated for residents with Covid-19. The findings and conclusion in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org. We thank the facility residents; the staff of Facility A for their ongoing efforts to provide care in the face of these challenges; staff at the local and state health departments responding to this public health emergency; staff at the Washington State De- partment of Health Public Health Laboratories; CDC staff at the Emergency Operations Center; and members of the Covid-19 response teams at the local, state, and national levels for their unwavering commitment in the face of this global public health emergency. Appendix The authors’ full names and academic degrees are as follows: Melissa M. Arons, R.N., Kelly M. Hatfield, M.S.P.H., Sujan C. Reddy, M.D., Anne Kimball, M.D., Allison James, Ph.D., Jesica R. Jacobs, Ph.D., Joanne Taylor, Ph.D., Kevin Spicer, M.D., Ana C. Bardossy, M.D., Lisa P. Oakley, Ph.D., Sukarma Tanwar, M.Med., Jonathan W. Dyal, M.D., Josh Harney, M.S., Zeshan Chisty, M.P.H., Jeneita M. Bell, M.D., Mark Methner, Ph.D., Prabasaj Paul, Ph.D., Christina M. Carlson, Ph.D., Heather P. McLaughlin, Ph.D., Natalie Thornburg, Ph.D., Suxiang Tong, Ph.D., Azaibi Tamin, Ph.D., Ying Tao, Ph.D., Anna Uehara, Ph.D., Jennifer Harcourt, Ph.D., Shauna Clark, R.N., Claire Brostrom‑Smith, M.S.N., Libby C. Page, M.P.H., Meagan Kay, D.V.M., James Lewis, M.D., Patty Montgomery, M.P.H., Nimalie D. Stone, M.D., Thomas A. Clark, M.D., Margaret A. Honein, Ph.D., Jeffrey S. Duchin, M.D., and John A. Jernigan, M.D. The authors’ affiliations are as follows: the Centers for Disease Control and Prevention COVID-19 Emergency Response (M.M.A., K.M.H., S.C.R., A.K., A.J., J.R.J., J.T., K.S., A.C.B., L.P.O., S. Tanwar, J.W.D., J. Harney, Z.C., J.M.B., M.M., P.P., C.M.C., H.P.M.L., N.T., S. Tong, A.T., Y.T., A.U., J. Harcourt, N.D.S., T.A.C., M.A.H., J.A.J.), and the Epidemic Intelligence Service (M.M.A., A.K., A.J., J.T., A.C.B., L.P.O., S. Tanwar, J.W.D.) and the Laboratory Leadership Service (J.R.J., C.M.C.), Centers for Disease Control and Preven- tion — all in Atlanta; and Public Health — Seattle King County (S.C., C.B.-S., L.C.P., M.K., J.L., J.S.D.) and the University of Wash- ington, Department of Medicine (J.S.D.), Seattle, the Washington State Public Health Laboratory, Shoreline (J.S.D.), and the Washington State Department of Health, Tumwater (P.M.) — all in Washington. References 1. Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med 2020; 382:929-36. 2. McMichael TM, Currie DW, Clark S, et al. Epidemiology of Covid-19 in a long- term care facility in King County, Wash- ington. N Engl J Med. DOI:10.1056/ NEJMoa2005412. 3. McMichael TM, Clark S, Pogosjans S, et al. COVID-19 in a long-term care facil- ity — King County, Washington, February 27–March 9, 2020. MMWR Morb Mortal Wkly Rep 2020;69:339-42. 4. Kimball A, Hatfield KM, Arons M, et al. Asymptomatic and presymptomatic SARS- CoV-2 infections in residents of a long-term care skilled nursing facility — King County, Washington, March 2020. MMWR Morb Mortal Wkly Rep 2020;69:377-81. 5. Centers for Disease Control and Pre- vention. Preparing for COVID-19: long- term care facilities, nursing homes. 2020 (https://www.cdc.gov/coronavirus/2019 -ncov/healthcare-facilities/prevent-spread -in-long-term-care-facilities.html). 6. Centers for Disease Control and Pre- vention. Interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 The New England Journal of Medicine Downloaded from nejm.org by ROD STER on April 24, 2020. For personal use only. No other uses without permission. Copyright © 2020 Massachusetts Medical Society. All rights reserved.
10.
n engl j
med nejm.org10 The new engl and jour nal of medicine (COVID-19). 2020 (https://www.cdc.gov/ coronavirus/2019-ncov/lab/guidelines -clinical-specimens.html). 7. Centers for Disease Control and Pre- vention. Symptoms. Coronavirus 2019 (COVID-19). 2020 (https://www.cdc.gov/ coronavirus/2019-ncov/symptoms -testing/symptoms.html). 8. Centers for Disease Control and Pre- vention. Real-time RT-PCR panel for detec- tion 2019-novel coronavirus. 2020 (https:// www.cdc.gov/coronavirus/2019-ncov/ downloads/rt-pcr-panel-for-detection -instructions.pdf). 9. Centers for Disease Control and Pre- vention. 2019-Novel coronavirus (2019- nCoV) real-time rRT-PCR panel primers and probes. 2020 (https://www.cdc.gov/ coronavirus/2019-ncov/downloads/rt-pcr -panel-primer-probes.pdf). 10. Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: molecular evolu- tionary genetics analysis across comput- ing platforms. Mol Biol Evol 2018;35: 1547-9. 11. Public Health — Seattle and King County. COVID-19 data dashboard: King County COVID-19 outbreak summary (https://kingcounty.gov/depts/health/ communicable-diseases/disease-control/ novel-coronavirus/data-dashboard .aspx). 12. Wei WE, Li Z, Chiew CJ, Yong SE, Toh MP, Lee VJ. Presymptomatic transmission of SARS-CoV-2 — Singapore, January 23– March 16, 2020. MMWR Morb Mortal Wkly Rep 2020;69:411-5. 13. Tong Z-D, Tang A, Li K-F, et al. Poten- tial presymptomatic transmission of SARS-CoV-2, Zhejiang Province, China, 2020. Emerg Infect Dis 2020;26:1052-4. 14. Qian G, Yang N, Ma AHY, et al. A COVID-19 transmission within a family cluster by presymptomatic infectors in China. Clin Infect Dis 2020 March 23 (Epub ahead of print). 15. Chow EJ, Schwartz NG, Tobolowsky FA, et al. Symptom screening at illness onset of health care personnel with SARS- CoV-2 infection in King County, Washing- ton. JAMA 2020 April 17 (Epub ahead of print). 16. Aw D, Silva AB, Palmer DB. Immu- nosenescence: emerging challenges for an ageing population. Immunology 2007; 120:435-46. 17. Lam P-P, Coleman BL, Green K, et al. Predictors of influenza among older adults in the emergency department. BMC Infect Dis 2016;16:615. 18. Sayers G, Igoe D, Carr M, et al. High morbidity and mortality associated with an outbreak of influenza A(H3N2) in a psycho-geriatric facility. Epidemiol Infect 2013;141:357-65. 19. Zou L, Ruan F, Huang M, et al. SARS- CoV-2 viral load in upper respiratory spec- imens of infected patients. N Engl J Med 2020;382:1177-9. 20. To KK-W, Tsang OT-Y, Leung W-S, et al. Temporal profiles of viral load in pos- terior oropharyngeal saliva samples and serum antibody responses during infec- tion by SARS-CoV-2: an observational co- hort study. Lancet Infect Dis 2020 March 23 (Epub ahead of print). 21. Young BE, Ong SWX, Kalimuddin S, et al. Epidemiologic features and clinical course of patients infected with SARS- CoV-2 in Singapore. JAMA 2020 March 03 (Epub ahead of print). 22. Centers for Disease Control and Pre- vention. Discontinuation of transmission- based precautions and disposition of pa- tients with COVID-19 in healthcare settings (interim guidance). 2020 (https:// www.cdc.gov/coronavirus/2019-ncov/hcp/ disposition-hospitalized-patients.html). Copyright © 2020 Massachusetts Medical Society. The New England Journal of Medicine Downloaded from nejm.org by ROD STER on April 24, 2020. For personal use only. No other uses without permission. Copyright © 2020 Massachusetts Medical Society. All rights reserved.
Download now